Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphotic leukemia

Hematology and Cell Therapy

Volumn 39, Issue 4, 1997, Pages 209-212

  Bay, J O ^a   Fouassier, M ^b   Beal D ^a   Alcaraz, L ^a   Cure, H ^a   Chollet, P ^a   Plagne, R ^a   Travade, P ^b  

^a CENTRE JEAN PERRIN   (France)

^b HÔTEL DIEU   (France)

Author keywords

Autoimmune thrombocytopenia; Chronic lymphocytic leukemia; Fludarabine

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE PHOSPHATE; IFOSFAMIDE; PREDNISONE; VINCRISTINE SULFATE;

ARTICLE; AUTOIMMUNITY; B CELL LEUKEMIA; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; SIDE EFFECT; THROMBOCYTOPENIA;

AGED; AUTOIMMUNE DISEASES; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; THROMBOCYTOPENIA; VIDARABINE PHOSPHATE;

EID: 0030807337     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0209-y     Document Type: Article

References (15)

1. Borche L, Lim A, Binet JL, Dighiero G (1990) Evidence that chronic lymphocitic leukemia B lymphocytes are frequently committed to production of natural antibodies. Blood 76: 562-570
2. Dighiero G (1988) An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL. Nouv Rev Fr Hematol 30: 283-288
3. Dighiero G, Travade P, Chevret S, et al. (1991) B-Cell chronic lymphocytic leukemia: present status and future directions. Blood 8: 1901-1914
4. DiRaimondi F, Guistolisi R, Cacciola E, et al. (1993) Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 11: 63-68
5. Gale RP, Foon KA (1987) Biology of chronic lymphocytic leukemia. Semin Hematol 4: 209-229
6. Hamblin TJ, Oscier DJ, Young BJ (1986) Autoimmunity in chronic lymphocytic leukemia. J Clin Pathol 39: 713-716
7. Keating MJ (1990) Fludarabine Phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol 17: 49-62
8. Keating MJ, O'Brien S, McLaughlin P, et al. (1996) Clinical experience with fludarabine in hemato-oncology. Hematol Cell Ther 38: S83-S91
9. Maclean R, Meiklejohn D, Soutar R (1996) Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukemia. Br J Haematol 92: 768-769
10. Montillo M, Tedeschi A, Leoni P (1994) Recurrence of autoimmune thrombocytopenia after treatment with Fludarabine in a patient with chronic lymphocytic leukemia. Leuk Lymphoma 47: 187-188
11. Myint H, Copplestone JA, Orchard J, et al. (1995) Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 91: 341-344
12. O'Brien S, Kantarjian H, Beran M, et al. (1993) Results of Fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 6: 1695-1700
13. Tertian G, Cartron J, Bayle C, et al. (1996) Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia. Hematol Cell Ther 38: 359-360
14. The French cooperative group on CLL, Johnson S, Smith AG, et al. (1996) Multicentre prospective randomized trial of fludarabine versus cyclophosphamide, doxorubicin and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. Lancet 347: 1432-1438
15. Sthoeger ZM, Wakai M, Tse DB, et al. (1989) Production of autoantibodies by CDS-expressing B lymphocytes from patients with chronic lymphocytoc leukemia. J Exp Med 169: 255-268